A Phase 1/2 Safety and Efficacy Study of JV-GL1 Applied to the Periorbital Skin in Subjects With Open-Angle Glaucoma or Ocular Hypertension

NCT04761705 Phase 1/Phase 2 SUSPENDED

The aim of this research study is to assess the safety and feasibility of lowering intraocular pressure (IOP) using an experimental study drug, JV-GL1.

Details

Lead sponsor	JeniVision, Inc.
Phase	Phase 1/Phase 2
Status	SUSPENDED
Enrolment	70
Start date	2021-03-10
Completion	2025-07

Conditions

• Ocular Hypertension
• Open Angle Glaucoma

Interventions

• JV-GL1
• Latanoprost 0.005% Ophthalmic Solution

Primary outcomes

• Intraocular Pressure (IOP) — From Baseline to Day 28 of Treatment
  Change from baseline in Intraocular Pressure (IOP)

Countries

United States